These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
562 related articles for article (PubMed ID: 24356256)
1. Motavizumab treatment of infants hospitalized with respiratory syncytial virus infection does not decrease viral load or severity of illness. Ramilo O; Lagos R; Sáez-Llorens X; Suzich J; Wang CK; Jensen KM; Harris BS; Losonsky GA; Griffin MP; Pediatr Infect Dis J; 2014 Jul; 33(7):703-9. PubMed ID: 24356256 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial. O'Brien KL; Chandran A; Weatherholtz R; Jafri HS; Griffin MP; Bellamy T; Millar EV; Jensen KM; Harris BS; Reid R; Moulton LH; Losonsky GA; Karron RA; Santosham M; Lancet Infect Dis; 2015 Dec; 15(12):1398-408. PubMed ID: 26511956 [TBL] [Abstract][Full Text] [Related]
3. Safety and antiviral activity of motavizumab, a respiratory syncytial virus (RSV)-specific humanized monoclonal antibody, when administered to RSV-infected children. Lagos R; DeVincenzo JP; Muñoz A; Hultquist M; Suzich J; Connor EM; Losonsky GA Pediatr Infect Dis J; 2009 Sep; 28(9):835-7. PubMed ID: 19636278 [TBL] [Abstract][Full Text] [Related]
4. Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage. Romero JR Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S46-54. PubMed ID: 12671452 [TBL] [Abstract][Full Text] [Related]
5. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173 [TBL] [Abstract][Full Text] [Related]
6. Effect of dexamethasone on tracheal viral load and interleukin-8 tracheal concentration in children with respiratory syncytial virus infection. van Woensel JB; Lutter R; Biezeveld M; Dekker T; Nijhuis M; van Aalderen WM; Kuijpers TW Pediatr Infect Dis J; 2003 Aug; 22(8):721-6. PubMed ID: 12913774 [TBL] [Abstract][Full Text] [Related]
7. Respiratory syncytial virus genomic load and disease severity among children hospitalized with bronchiolitis: multicenter cohort studies in the United States and Finland. Hasegawa K; Jartti T; Mansbach JM; Laham FR; Jewell AM; Espinola JA; Piedra PA; Camargo CA J Infect Dis; 2015 May; 211(10):1550-9. PubMed ID: 25425699 [TBL] [Abstract][Full Text] [Related]
8. Relating plaque morphology to respiratory syncytial virus subgroup, viral load, and disease severity in children. Kim YI; Murphy R; Majumdar S; Harrison LG; Aitken J; DeVincenzo JP Pediatr Res; 2015 Oct; 78(4):380-8. PubMed ID: 26107392 [TBL] [Abstract][Full Text] [Related]
9. Azithromycin does not improve disease course in hospitalized infants with respiratory syncytial virus (RSV) lower respiratory tract disease: a randomized equivalence trial. Kneyber MC; van Woensel JB; Uijtendaal E; Uiterwaal CS; Kimpen JL; Pediatr Pulmonol; 2008 Feb; 43(2):142-9. PubMed ID: 18085694 [TBL] [Abstract][Full Text] [Related]
10. Respiratory syncytial virus infections in hospitalized infants: association between viral load, virus subgroup, and disease severity. Fodha I; Vabret A; Ghedira L; Seboui H; Chouchane S; Dewar J; Gueddiche N; Trabelsi A; Boujaafar N; Freymuth F J Med Virol; 2007 Dec; 79(12):1951-8. PubMed ID: 17935185 [TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection. Sanders SL; Agwan S; Hassan M; van Driel ML; Del Mar CB Cochrane Database Syst Rev; 2019 Aug; 8(8):CD009417. PubMed ID: 31446622 [TBL] [Abstract][Full Text] [Related]
12. Natural infection of infants with respiratory syncytial virus subgroups A and B: a study of frequency, disease severity, and viral load. Devincenzo JP Pediatr Res; 2004 Dec; 56(6):914-7. PubMed ID: 15470202 [TBL] [Abstract][Full Text] [Related]
13. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. Simoes EA; Carbonell-Estrany X Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448 [TBL] [Abstract][Full Text] [Related]
14. Comparison of human metapneumovirus, respiratory syncytial virus and influenza A virus lower respiratory tract infections in hospitalized young children. Wolf DG; Greenberg D; Kalkstein D; Shemer-Avni Y; Givon-Lavi N; Saleh N; Goldberg MD; Dagan R Pediatr Infect Dis J; 2006 Apr; 25(4):320-4. PubMed ID: 16567983 [TBL] [Abstract][Full Text] [Related]
15. Hospitalization for respiratory syncytial virus bronchiolitis and disease severity in twins. Dotan M; Ashkenazi-Hoffnung L; Samra Z; Livni G; Yarden-Bilavsky H; Amir J; Bilavsky E Isr Med Assoc J; 2013 Nov; 15(11):701-4. PubMed ID: 24511652 [TBL] [Abstract][Full Text] [Related]
16. Nosocomial respiratory syncytial virus infections in the palivizumab-prophylaxis era with implications regarding high-risk infants. Ashkenazi-Hoffnung L; Dotan M; Livni G; Amir J; Bilavsky E Am J Infect Control; 2014 Sep; 42(9):991-5. PubMed ID: 25179332 [TBL] [Abstract][Full Text] [Related]